Eradication of hepatitis C virus after a 5-week treatment

被引:0
|
作者
Mbethe, G. L. Gaundong [1 ]
Foucher, J. [1 ]
DeLedinghen, V. [1 ]
Couzigou, V. P. [1 ]
机构
[1] CHU Bordeaux, Hop Haute Leveque, Serv Hepatogastroenterol, F-33604 Pessac, France
来源
REVUE DE MEDECINE INTERNE | 2009年 / 30卷 / 10期
关键词
Chronic hepatitis C; Genotype; 2; Short-term therapy; PEGINTERFERON ALPHA-2B; COMBINATION THERAPY; HCV GENOTYPE-2; RIBAVIRIN; INTERFERON;
D O I
10.1016/j.revmed.2009.03.358
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The standard regimen for the treatment of chronic hepatitis C virus (HCV) is peginterferon alpha-2a or -2b associated with ribavirine. The recommended duration of treatment for genotype 2 HCV infection is 24 weeks. However, the relatively poor drug tolerance often leads to a reduction or a discontinuation of the treatment. Here, we report two female patients who discontinued antiviral therapy after less than 6 weeks for intolerance and who experienced a sustained virological response. A treatment of 3 to 5 weeks may be enough for genotype 2 HCV eradication. However, there is not sufficient evidence in 2009 to recommend a reduced treatment duration. (C) 2009 Societe nationale francaise de medecine interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:900 / 903
页数:4
相关论文
共 50 条
  • [41] Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus
    Tachi, Yoshihiko
    Hirai, Takanori
    Toyoda, Hidenori
    Tada, Toshifumi
    Hayashi, Kazuhiko
    Honda, Takashi
    Ishigami, Masatoshi
    Goto, Hidemi
    Kumada, Takashi
    PLOS ONE, 2015, 10 (07):
  • [42] Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/hepatitis C virus coinfected women
    French, Audrey L.
    Grennan, Dara
    Daubert, Elizabeth
    Seaberg, Eric C.
    Peters, Marion
    Augenbraun, Michael
    Fischl, Margaret
    Kassaye, Seble
    Franco, Ricardo
    Kuniholm, Mark
    Adimora, Adaora A.
    Workowski, Kimberly
    Weber, Kathleen M.
    AIDS, 2021, 35 (09) : 1433 - 1438
  • [43] What happens after hepatitis C eradication?
    Pol, Stanislas
    RETROVIROLOGY, 2012, 9
  • [44] Long-term outcomes after hepatitis C virus eradication: a message for clinicians
    Gentilcore, Elena
    MINERVA MEDICA, 2019, 110 (06) : 487 - 489
  • [45] What happens after hepatitis C eradication?
    Stanislas Pol
    Retrovirology, 9
  • [46] Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection
    Trifan, Anca
    Cuciureanu, Tudor
    Nastasa, Robert
    Stratina, Ermina
    Zenovia, Sebastian
    Muzica, Cristina Maria
    Huiban, Laura
    Singeap, Ana-Maria
    Chiriac, Stefan
    Sfarti, Catalin
    Cojocariu, Camelia
    Girleanu, Irina
    Minea, Horia
    Stafie, Remus
    Rotaru, Adrian
    Stanciu, Carol
    LIFE-BASEL, 2023, 13 (02):
  • [47] Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes
    Younossi, Zobair M.
    Stepanova, Maria
    Jacobson, Ira
    Muir, Andrew J.
    Pol, Stanislas
    Zeuzem, Stefan
    Younes, Ziad
    Herring, Robert
    Lawitz, Eric
    Younossi, Issah
    Racila, Andrei
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (04) : 628 - 632
  • [48] The impact of hepatitis C virus eradication on hepatocarcinogenesis in haemophiliacs
    Inukai, Yosuke
    Imai, Norihiro
    Yamamoto, Kenta
    Ito, Takanori
    Ishizu, Yoji
    Honda, Takashi
    Ishigami, Masatoshi
    JOURNAL OF HEPATOLOGY, 2021, 75 : S787 - S788
  • [49] Impact of hepatitis C virus eradication on hepatocellular carcinogenesis
    Li, Darrick K.
    Chung, Raymond T.
    CANCER, 2015, 121 (17) : 2874 - 2882
  • [50] Eradication hepatitis C virus and prevention of clinical endpoints
    Hardtke, S.
    Wedemeyer, H.
    GASTROENTEROLOGE, 2015, 10 (04): : 305 - 309